Sep 04, 2019 / 05:30PM GMT
Yigal Dov Nochomovitz - Citigroup Inc, Research Division - Director
The next panel is cell therapy, up-and-comers in the cell therapy space. So it's my pleasure to introduce our 3 distinguished guests, from Atara the CEO, Pascal Touchon; and from Cellectis, André Choulika; and, of course, from Fate, in the middle, Scott Wolchko. So welcome all of you. Thanks for making the time.
Questions and Answers:
Yigal Dov Nochomovitz - Citigroup Inc, Research Division - DirectorI guess the question I have to start out the session is at a 30,000-foot level, could each of you give your thoughts on what are the ingredients to create a successful cell therapy? What are the things you want to do? And what are the things that you absolutely want to avoid on the path to a product that's a cell-based therapy? So you want to kick it off, Pascal?
Pascal Touchon - Atara Biotherapeutics, Inc. - President, CEO & Director
Yes, with pleasure. I mean thank you for inviting me, by the way.
Yigal Dov Nochomovitz<
Trustpilot
